Study proves hepatitis C drugs reduce liver-related deaths by nearly half
A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.
Aug 9, 2019
0
49